Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BATEMAN UPF-III BIPOLAR ENDOPROSTHESIS SYSTEM

K-Number: K913632 · 1991-11-13

ApplicantKirschner Medical Corp.
Decision Date1991-11-13
Product CodeKWY
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

BATEMAN UPF-III BIPOLAR ENDOPROSTHESIS SYSTEM is the device name listed in this FDA 510(k) record. The listed applicant is Kirschner Medical Corp.. It received FDA 510(k) clearance on 1991-11-13 under 510(k) number K913632. The device is classified under product code KWY. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BATEMAN UPF-III BIPOLAR ENDOPROSTHESIS SYSTEM?

BATEMAN UPF-III BIPOLAR ENDOPROSTHESIS SYSTEM is a medical device that received FDA 510(k) clearance on 1991-11-13. The listed applicant is Kirschner Medical Corp.. The 510(k) number is K913632.

When did BATEMAN UPF-III BIPOLAR ENDOPROSTHESIS SYSTEM receive FDA 510(k) clearance?

BATEMAN UPF-III BIPOLAR ENDOPROSTHESIS SYSTEM received FDA 510(k) clearance on 1991-11-13, under 510(k) number K913632.

Who is the listed applicant for BATEMAN UPF-III BIPOLAR ENDOPROSTHESIS SYSTEM?

The FDA 510(k) record lists Kirschner Medical Corp. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for BATEMAN UPF-III BIPOLAR ENDOPROSTHESIS SYSTEM?

The FDA product code for BATEMAN UPF-III BIPOLAR ENDOPROSTHESIS SYSTEM is KWY.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Kirschner Medical Corp. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K940537KIRSCHNER(R) MODULAR II-C(TM) TOTAL SHOULDER SYSTEMK936274KIRSCHNER PERFORMANCE POSTERIOR STABILIZED TOTAL KNEE SYSTEMK942891SUMMIT TOTAL HIP SYSTEMK941486INTEGRITY TOTAL HIP SYSTEM, NON-POROUSK933843LINE EXTENSION FOR KIRSCHNER PERFORMANCE TOTAL KNEE SYSTEM, POROUS COATEDK935951KIRSCHNER C-2 OSTEOCAP TOTAL HIP SYSTEM

View all 76 devices →

Related Devices (Code: KWY)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K253357b-ONE® Bipolar HeadB-One Ortho, Corp.K243634Maxx Libertas Bipolar Hip Head (Bipolar Hip)Maxx Orthopedics, Inc.K231526CORAIL Cemented Femoral StemDepuy Ireland UCK223441SpaceFlex Acetabular CupG21, S.R.L.K221794Vario-Cup SystemWaldemar Link GmbH & Co. KGK220492COPAL exchange G hip spacerHeraeus Medical GmbH

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑